H.C. Wainwright raised the firm’s price target on Delcath Systems to $20 from $18 and keeps a Buy rating on the shares following the Q4 report. The analyst is re encouraged by the positive launch metrics Hepzato has achieved to date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCTH:
- Delcath Systems, Inc. Under ESG Spotlight: Navigating New Compliance Challenges and Financial Implications
- Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
- Is DCTH a Buy, Before Earnings?
- Delcath Systems Welcomes New COO Martha S. Rook
- Delcath Systems names Martha Rook as COO